Ventricular Tachycardia and Sudden Death in Myotonic Dystrophy
Overview
Affiliations
Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1.
Berenger-Currias N, Martinat C, Baghdoyan S Cells. 2023; 12(4).
PMID: 36831237 PMC: 9954118. DOI: 10.3390/cells12040571.
Poulin H, Mercier A, Djemai M, Pouliot V, Deschenes I, Boutjdir M Sci Rep. 2021; 11(1):2500.
PMID: 33510259 PMC: 7844414. DOI: 10.1038/s41598-021-82007-8.
Pang P, Alsina K, Cao S, Koushik A, Wehrens X, Cooper T J Am Heart Assoc. 2018; 7(19):e010393.
PMID: 30371314 PMC: 6404881. DOI: 10.1161/JAHA.118.010393.
Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease.
Givvimani S, Qipshidze N, Tyagi N, Mishra P, Sen U, Tyagi S Int J Physiol Pathophysiol Pharmacol. 2011; 3(2):107-19.
PMID: 21760969 PMC: 3134005.
Koshelev M, Sarma S, Price R, Wehrens X, Cooper T Hum Mol Genet. 2010; 19(6):1066-75.
PMID: 20051426 PMC: 2830830. DOI: 10.1093/hmg/ddp570.